Nature, nurture and neurology: gene-environment interactions in neurodegenerative disease. FEBS Anniversary Prize Lecture delivered on 27 June 2004 at the 29th FEBS Congress in Warsaw
- PMID: 15885086
- DOI: 10.1111/j.1742-4658.2005.04677.x
Nature, nurture and neurology: gene-environment interactions in neurodegenerative disease. FEBS Anniversary Prize Lecture delivered on 27 June 2004 at the 29th FEBS Congress in Warsaw
Abstract
Neurodegenerative disorders, such as Huntington's, Alzheimer's, and Parkinson's diseases, affect millions of people worldwide and currently there are few effective treatments and no cures for these diseases. Transgenic mice expressing human transgenes for huntingtin, amyloid precursor protein, and other genes associated with familial forms of neurodegenerative disease in humans provide remarkable tools for studying neurodegeneration because they mimic many of the pathological and behavioural features of the human conditions. One of the recurring themes revealed by these various transgenic models is that different diseases may share similar molecular and cellular mechanisms of pathogenesis. Cellular mechanisms known to be disrupted at early stages in multiple neurodegenerative disorders include gene expression, protein interactions (manifesting as pathological protein aggregation and disrupted signaling), synaptic function and plasticity. Recent work in mouse models of Huntington's disease has shown that enriching the environment of transgenic animals delays the onset and slows the progression of Huntington's disease-associated motor and cognitive symptoms. Environmental enrichment is known to induce various molecular and cellular changes in specific brain regions of wild-type animals, including altered gene expression profiles, enhanced neurogenesis and synaptic plasticity. The promising effects of environmental stimulation, demonstrated recently in models of neurodegenerative disease, suggest that therapy based on the principles of environmental enrichment might benefit disease sufferers and provide insight into possible mechanisms of neurodegeneration and subsequent identification of novel therapeutic targets. Here, we review the studies of environmental enrichment relevant to some major neurodegenerative diseases and discuss their research and clinical implications.
Similar articles
-
Enriched environments, experience-dependent plasticity and disorders of the nervous system.Nat Rev Neurosci. 2006 Sep;7(9):697-709. doi: 10.1038/nrn1970. Nat Rev Neurosci. 2006. PMID: 16924259 Review.
-
Environmental enrichment and neurodegenerative diseases.Biochem Biophys Res Commun. 2005 Aug 26;334(2):293-7. doi: 10.1016/j.bbrc.2005.05.162. Biochem Biophys Res Commun. 2005. PMID: 15961061
-
What transgenic mice tell us about neurodegenerative disease.Bioessays. 2000 Mar;22(3):297-304. doi: 10.1002/(SICI)1521-1878(200003)22:3<297::AID-BIES12>3.0.CO;2-I. Bioessays. 2000. PMID: 10684590 Review.
-
Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.J Neurol Sci. 2005 Jun 15;233(1-2):145-62. doi: 10.1016/j.jns.2005.03.012. J Neurol Sci. 2005. PMID: 15896810 Review.
-
Genes and the environment in neurodegeneration.Biosci Rep. 2006 Oct;26(5):341-67. doi: 10.1007/s10540-006-9028-6. Biosci Rep. 2006. PMID: 17029001 Review.
Cited by
-
No Country for Old Worms: A Systematic Review of the Application of C. elegans to Investigate a Bacterial Source of Environmental Neurotoxicity in Parkinson's Disease.Metabolites. 2018 Oct 29;8(4):70. doi: 10.3390/metabo8040070. Metabolites. 2018. PMID: 30380609 Free PMC article. Review.
-
Effects of enhanced environment and induced depression on cuprizone mouse model of demyelination.Exp Ther Med. 2019 Jul;18(1):566-572. doi: 10.3892/etm.2019.7654. Epub 2019 Jun 10. Exp Ther Med. 2019. PMID: 31281443 Free PMC article.
-
Factors influencing the clinical expression of intermediate CAG repeat length mutations of the Huntington's disease gene.J Neurol. 2015 Feb;262(2):277-84. doi: 10.1007/s00415-014-7559-5. Epub 2014 Nov 8. J Neurol. 2015. PMID: 25380582
-
A bacterial metabolite induces glutathione-tractable proteostatic damage, proteasomal disturbances, and PINK1-dependent autophagy in C. elegans.Cell Death Dis. 2015 Oct 15;6(10):e1908. doi: 10.1038/cddis.2015.270. Cell Death Dis. 2015. PMID: 26469957 Free PMC article.
-
Passive immunotherapy rapidly increases structural plasticity in a mouse model of Alzheimer disease.Neurobiol Dis. 2009 Feb;33(2):213-20. doi: 10.1016/j.nbd.2008.10.011. Epub 2008 Nov 6. Neurobiol Dis. 2009. PMID: 19028582 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical